Background: The management of cow's milk allergy (CMA) includes initial dairy exclusion with suitable dietary substitution, diagnostic challenges where indicated, and supervised re-introduction as the condition resolves. Information on clinician practice is limited. We audited the current practice of clinicians in the UK to evaluate adherence to international guidelines. Methods: An online questionnaire was sent to all clinicians whose practice included children identified on the national allergy society website. One hundred and sixty questionnaires were sent and 116 (73%) responded. Results: Skin prick tests were more commonly used than serum-specific IgE as diagnostic tests. Respective proportions selecting amino acid formulas (AAF) or extensively hydrolysed formulas (EHF) in severe versus mild/moderate presentations were 78 and 40% versus 20 and 88%; soya formula was the first choice in 8.6 and 24%. The criteria for selection of AAF as the first choice were predominantly severe IgE-mediated and non-IgE-mediated reactions, failure to thrive and if infants refused EHF. Oral challenges might be used to diagnose CMA in 69%, whereas nearly 90% performed challenges to assess tolerance. Most of these were open challenges, more commonly with fresh milk (90%) than baked milk (60%). Home baked milk challenges were frequently considered (70%), although only after consideration of the clinical scenario. Practice did not vary with experience. Conclusions: Current practice amongst UK clinicians of the management of CMA is broadly in line with current guidance, particularly the positioning of hypoallergenic milks as substitute milk choices. A notable deviation was the use of home baked milk challenges or re-introduction.

Keywords:
Child, National audit, Current UK practice, Milk allergy
1.
Fiocchi A, Brozek J, Schünemann HJ, Bahna SL, von Berg A, Beyer K, Bozzola M, Bradsher J, Compalati E, Ebisawa M, Guzman MA, Li H, Heine RG, Keith P, Lack G, Landi M, Martelli A, Rancė F, Sampson H, Stein A, Terraciano L, Vieths S: World Allergy Organization (WAO) diagnosis and rationale for action against cow's milk allergy (DRACMA). World Allergy Organ J 2010;3:57-161.
2.
Venter C, Pereira B, Voigt K, Grundy J, Clayton CB, Higgins B, Arshad SH, Dean T: Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life. Allergy 2008;63:354-359.
3.
Lack G: Update on risk factors for food allergy. J Allergy Clin Immunol 2012;129:1187-1197.
4.
Wood RA, Sicherer SH, Vickery BP, Jones SM, Liu AH, Fleischer DM, Henning AK, Mayer L, Burks AW, Grishin A, Stablein D, Samson HA: The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol 2013;131:805-812.
5.
Sladkevicius E, Nagy E, Lack G, Guest JF: Resource implications and budget impact of managing cow milk allergy in the UK. J Med Econ 2010;13:119-128.
6.
Klemola T, Vanto T, Juntunen-Backman K, Kalimo K, Korpela R, Varjonen E: Allergy to soy formula and to extensively hydrolyzed whey formula in infants with cow's milk allergy: a prospective, randomized study with a follow-up to the age of 2 years. J Pediatr 2002;140:219-224.
7.
Restani P, Beretta B, Fiocchi A, Ballabio C, Galli CL: Cross-reactivity between mammalian proteins. Ann Allergy Asthma Immunol 2002;89:11-15.
8.
Department of Health: Advice on infant milk based on goat's milk. London, Department of Health, 2006.
9.
Sladkevicius E, Guest JF: Modelling the health economic impact of managing cow milk allergy in South Africa. J Med Econ 2010;13:257-272.
10.
Koletzko S, Niggemann B, Arato A, Dias JA, Heuschkel R, Husby S, Mearin ML, Papadopolou A, Ruemmele FM, Staiano A, Schäppi, Vandenplas Y: Diagnostic approach and management of cow's-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr 2012;55:221-229.
11.
Allen KJ, Davidson GP, Day AS, Hill DJ, Kemp AS, Peake JE, Prescott SL, Shugg A, Heine RG: Management of cow's milk protein allergy in infants and young children: an expert panel perspective. J Pediatr Child Health 2009;45:481-486.
12.
Vandenplas Y, Brueton M, Dupont C, Hill D, Isolauri E, Koletzko S, Oranje AP, Satiano A, Dupont C: Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Arch Dis Child 2007;92:902-908.
13.
Kemp A: Hypoallergenic formula prescribing practices in Australia. J Pediatr Child Health 2006;42:191-195.
14.
Kim JS, Nowak-Wegrzyn A, Sicherer SH, Noone S, Moshier EL, Sampson HA: Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol 2011;128:125-131.
15.
De Boissieu D, Dupont C: Allergy to extensively hydrolysed cow's milk protein in infants: safety and duration of amino-acid formula. J Pediatr 2002;141:271-273.
16.
Scientific Advisory Committee on Nutrition: Soy based infant formula. SMCN/03/10. 2003.
17.
Burks AW, Tang M, Sicherer S, Muraro A, Eigenmann PA, Ebisawa M, Fiocchi A, Chiang W, Beyer K, Wood R, Hourihane J, Jones SM, Lack G, Sampson HA: ICON: food allergy. J Allergy Clin Immunol 2009;129:906-920.
18.
D'Urbano LE, Pellegrino K, Artesani MC, Donnanno S, Luciano R, Riccardi C, Torzi AE, Rava L, De Benedetti F, Cavagni G: Performance of a component-based allergen-microarray in the diagnosis of cow's milk and hen's egg allergy. Clin Exp Allergy 2010;40:1561-1570.
19.
Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, Bock A, Sicherer SH, Teuber SS: Work Group report: oral food challenge testing. J Allergy Clin Immunol 2009;123:S365-S383.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.